Results 71 to 80 of about 4,909 (178)

Immediate postoperative effects of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using carboplatin on peritoneal tissue inflammatory and ischemic responses: an explorative porcine study

Pleura and Peritoneum
This explorative porcine study investigated the immediate postoperative response of inflammatory protein markers and ischemic metabolites in peritoneal abdominal wall tissue during and after hyperthermic intraperitoneal chemotherapy (HIPEC) assessed by ...
Petersen Elisabeth Krogsgaard, Bue Mats, Harlev Christina, Jørgensen Andrea René, Hanberg Pelle, Petersen Lone Kjeld, Stilling Maiken   +6 more
doaj   +1 more source

Optimizing patient recovery: prospective study evaluating compliance and clinical outcomes of enhanced recovery protocols in ovarian cancer following cytoreductive surgery with HIPEC

Pleura and Peritoneum
To evaluate the implementation, compliance, and impact of the enhanced recovery after surgery (ERAS) protocol on perioperative outcomes in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for Stage ...
Somashekhar S. P., Rohit Kumar C., Fernandes Aaron, Ahuja Vijay, Aggarwal Kushal, Shanbhag Esha, Ashwin K. R.   +6 more
doaj   +1 more source

Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?

Current Issues in Pharmacy and Medical Sciences, 2019
Background and objectives. During the two past decades, a new therapeutic approach to ovarian cancer (OC) has been developed. This combines cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Yarema Roman, Volodko Nataliya, Fetsych Taras, Оhorchak Myron, Petronchak Orest, Mylyan Yuriy, Makukh Halyna   +6 more
doaj   +1 more source

Hyperthermic Intraoperative Thoracoabdominal Chemotherapy

Gastroenterology Research and Practice, 2012
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment option for selected patients with pseudomyxoma peritonei (PMP) and diffuse malignant peritoneal mesothelioma (DMPM).
Paul H. Sugarbaker, David Chang, O. Anthony Stuart   +2 more
doaj   +1 more source

Retrospective observational study of right hemicolectomy with hyperthermic intraperitoneal chemotherapy for appendiceal mucinous neoplasms at a single center over seven years

World Journal of Surgical Oncology
Objective Retrospective analysis of the safety and efficacy of radical right hemicolectomy combined with hyperthermic intraperitoneal chemotherapy in the treatment of appendiceal mucinous tumors.
lanzhu Jiang, Yingchao Hu, Hao Zheng, Zilong Zhang   +3 more
doaj   +1 more source

A Clinician's perspective on the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer management

Surgical Oncology
The prevention of intraperitoneal spread is of utmost importance in the management of advanced ovarian cancer (OC), thus demanding the exploration of innovative treatment techniques. The propensity of OC to spread to the peritoneum has highlighted the potential of local therapy as a promising approach. Among the proposed treatments thus far are several
Tomasz Ostrowski, Jakub Litwiński, Katarzyna Gęca, Izabela Świetlicka, Wojciech P. Polkowski, Magdalena Skórzewska   +5 more
openaire   +3 more sources

The impact of surgical staging in patients with colorectal peritoneal metastases scheduled for CRS-HIPEC

Pleura and Peritoneum
Surgical staging procedures are used to select patients with peritoneal metastases for surgery. We aimed to evaluate the impact of surgical staging procedures and the risk of abdominal wall recurrences in patients with peritoneal metastases scheduled for
Ghanipour Lana, Wallin Johan, Cashin Peter, Graf Wilhelm   +3 more
doaj   +1 more source

Thromboelastogram changes are associated with postoperative complications after cytoreductive surgery

Pleura and Peritoneum
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is used to treat peritoneal surface malignancies. However, surgical morbidity is high, and prediction of severe postoperative complications (SPC) is limited.
Goder Noam, Zac Lilach, Nevo Nadav, Gerstenhaber Fabian, Goren Or, Cohen Barak, Matot Idit, Lahat Guy, Nizri Eran   +8 more
doaj   +1 more source

Developing a hyperthermic intraperitoneal chemotherapy (HIPEC) gynecologic oncology program: a Canadian experience. [PDF]

Int J Gynecol Cancer, 2023
Neveu J, Tremblay E, Mercier F, Garneau S, Cormier B.   +4 more
europepmc   +1 more source

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

Cancer Management and Research, 2012
Daniel L Chan, David L Morris, Archana Rao, Terence C ChuaHepatobiliary and Surgical Oncology Unit, UNSW Department of Surgery, and the St George Clinical School, University of New South Wales, St George Hospital, Kogarah, NSW, AustraliaPurpose: To ...
Chua TC, Rao A, Morris DL, Chan DL
doaj